# Keren Kopilov

> Keren Kopilov is a Series A investor at Firstime Venture Capital backing Health Care and Medical. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Firstime Venture Capital](https://shizune.co/investors/profile/firsttime-venture-capital)
- Location: Tel Aviv-yafo, Israel
- Total investments: 4
- Last investment: Aug 2024
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/keren-kopilov-09922217/
- Facebook: https://www.facebook.com/keren.kopilov

Keren Kopilov is a Series A investor at Firstime Venture Capital in Tel Aviv-yafo focused on Health Care and Medical. Keren Kopilov is the Chief Financial Officer at thetime. She is the Chief Financial Officer at Firstime. Keren Kopilov is Former Chief Financial Officer at IPG Reuveni-Pridan. She has 15 years experience in financial management. Keren Kopilov is the Member of Board of Directors of Juvenile Diabetes Research Foundation, Israel. She received her BAin Economic and Business from the Hebrew University in Jerusalem in 1999, MBA in accounting and financial management from Tel Aviv University in 2003 and LL.B.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 75% |
| Medical | 2 | 50% |
| Diabetes | 1 | 25% |
| Robotics | 1 | 25% |
| Fertility | 1 | 25% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 25% |
| Series B | 1 | 25% |
| Funding Round | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 2 | 50% |
| United States | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Baibys | Baibys is a medical automated platform that provides AI and robotics-based autonomous sperm selection solutions for IVF. | $4.5M | Series A | Aug 08, 2024 |  |
| FeelBetter | FeelBetter is a healthcare optimization platform for value-based models identifying at-risk patients and interventions. The company was founded in 2018 and is based in Tel Aviv, Israel. | $5.9M |  | Jul 31, 2023 |  |
| HYGIEIA | Hygieia is a developer of a diabetes insulin guidance system used to enhance and simplify insulin therapy. It works by guiding users to adjust their insulin doses based on changing blood glucose patterns every few days rather than three or four times annually. Its insulin guidance device replaces a patient's existing glucose meter and providesindividually tailored insulin dosage recommendations between physician visits to result for the patients to monitor their diabetes levels digitally and also provides personalized adjustments to enhance and simplify it, maximizing insulin effectiveness and resulting in improved glycemic control.It was founded in 2008 by Eran Bashan and Israel Hodish in Ann Arbor, Michigan. | $5M | Series B | May 02, 2023 |  |
| HYGIEIA | Hygieia is a developer of a diabetes insulin guidance system used to enhance and simplify insulin therapy. It works by guiding users to adjust their insulin doses based on changing blood glucose patterns every few days rather than three or four times annually. Its insulin guidance device replaces a patient's existing glucose meter and providesindividually tailored insulin dosage recommendations between physician visits to result for the patients to monitor their diabetes levels digitally and also provides personalized adjustments to enhance and simplify it, maximizing insulin effectiveness and resulting in improved glycemic control.It was founded in 2008 by Eran Bashan and Israel Hodish in Ann Arbor, Michigan. | $17M | Series B | Dec 02, 2021 |  |

4 of 4 investments shown.

## Co-investors
- [Random Forest Ltd](https://shizune.co/investors/profile/random-forest-ltd) — VC Fund, 1 deal together
- [Rohto Pharmaceutical](https://shizune.co/investors/profile/rohto) — VC Fund, 1 deal together
- [Shoni Health Ventures](https://shizune.co/investors/profile/shoni-health-ventures) — VC Fund, 1 deal together
- [The Group Ventures](https://shizune.co/investors/profile/the-group-ventures) — VC Fund, 1 deal together
- [Triventures ARC](https://shizune.co/investors/profile/triventures-arc) — VC Fund, 1 deal together

## About Firstime Venture Capital

VC Fund · Tel Aviv, Israel

Firstime Venture Capital are a venture capital fund, investing in Pre A & A rounds, in cutting edge, disruptive technologies, based on state of the art ideas and headed by brilliant people.Firstime Venture Capital invest in 'digital life technologies' companies with a POC and initial customer base and provide them with the fundingthey need to peacefully strive to a product-market fit and generate initial revenues. This brings them to a solid KPIs achievement before seeking a proper A round.Digital Life Technologies, include: Mobile, Social, IOT, Video, E-commerce, Fintech, Ed-tech, Ad-tech, Cyber, AI, VR/AR, Digital Health, Gaming, Media, etc.

4 contacts available at Firstime Venture Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Jonathan Benartzi | Managing Partner | https://shizune.co/investors/profile/jonathan-benartzi |
| Keren Kopilov | Partner and CFO | https://shizune.co/investors/profile/keren-kopilov |
| Ilan Shiloah | Managing Partner | https://shizune.co/investors/profile/ilan-shiloah |
| Nir Tarlovsky | Managing Partner | https://shizune.co/investors/profile/nir-tarlovsky |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Keren Kopilov invest in?

Keren Kopilov invests primarily in Health Care, Medical and Diabetes startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Keren Kopilov last invest?

The most recent investment recorded for Keren Kopilov closed in Aug 2024. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co